Faith Ihekweazu, MD, MS
Department or Service
- Texas Medical Center
Assistant Professor of Pediatrics
Baylor College of Medicine
|Baylor College of Medicine||masters||Master of Clinical Investigation||2017|
|Baylor College of Medicine||fellowship||Pediatric Gastroenterology||2016|
|New York Presbyterian Hospital - Columbia Medical Center||internship/residency||Pediatrics||2012|
|Baylor College of Medicine||medical school||Doctor of Medicine||2009|
Dr. Ihekweazu’s clinical interests include general pediatric gastroenterology, with a primary focus on Inflammatory Bowel Diseases.
Dr. Ihekweazu’s research focuses on the relationship between the gut microbiome and Inflammatory bowel diseases (IBD), including Ulcerative Colitis and Crohn’s disease. Her ultimate goal is to better understand the disease process and provide more effective treatment options for patients with IBD, by targeting the microbiome. She is also involved in the Intestinal Microbiome Transplantation (IMT) program.
|American Gastroenterological Association||Member|
|Houston Medical Forum||Member|
|North American Society of Pediatric Gastroenterology, Hepatology and Nutrition||Member|
Ihekweazu FD, Ajjarapu A, Kellermayer R. Diagnostic Yield of Routine Enteropathogenic Stool Tests in Pediatric Ulcerative Colitis. Annals of Clinical and Laboratory Science 2015 Nov;45(6):639-42. PubMed PMID: 26663793.
Ihekweazu FD¸Kellermayer R. (2015) Fecal Microbiota Transplantation: is it time for children? In M. Manfredi & G.L. de’Angelis (Eds.), Probiotics in Children (pp 309-326) New York, NY: Nova Science Publishers, Inc.
Ihekweazu FD, Kellermayer R. Allopurinol: a Useful Adjunct to Thiopurine Therapy for Pediatric Ulcerative Colitis in the Biologic Era. Journal of Pediatric Gastroenterology and Nutrition 2014 Jul; 59(1):22-4. PubMed PMID: 24590210
Ihekweazu FD, Nagy-Szakal D, Fishman DS, Kellermayer R. Hyperlipasemia in Pediatric Inflammatory Bowel Diseases. Pancreas 2016 Feb;45(2):e2-3. PubMed PMID: 26752257
Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018 Nov; 365(5):413-423. PubMed PMID: 30384950.
Ihekweazu FD, Fofanova TY, Queliza K, Nagy-Szakal D, Stewart CJ, Engevik MA, Hulten KG, Tatevian N, Graham DY, Versalovic J, Petrosino JF, Kellermayer R. Bacteroides ovatus ATCC 8483 Monotherapy is Superior to Traditional Fecal Transplant and Multi-strain Bacteriotherapy in a Murine Colitis Model. Gut Microbes 2019 Jan 21:1-17. PubMed PMID: 30663928.
View PubMed Publications: